Delivery Order SPE2DB25D7067-SPE2DB26FSUFL
- Not listed
- The Defense Logistics Agency awarded a $2,010.96 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28S, a hormonal contraceptive medication. This is a firm fixed price, non-set-aside contract with a completion date of September 9, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,787.85 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lo Loestrin Fe 1-10 tablets (28-count packages). This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded without set-aside provisions and will...
- The Defense Logistics Agency awarded a $3,216.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive medication. The contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be completed by July 15, 2025, with services provided...
- The Defense Logistics Agency awarded a $4,912.24 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by September 17, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,075.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for Lo Loestrin Fe 1-10 tablets (28-count packages). This is a competitive award with no set-aside designation, with performance required at the vendor's facility in Conshohocken, Pennsylvania, and an ultimate completion date of April 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for Lo Loestrin Fe 1-10 tablets in a quantity of 28-unit packages at a firm fixed price of $1,050.53. This non-set-aside competitive award, with an ultimate completion date of October 30, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,793.99 firm fixed-price delivery order for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,599.91 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive pharmaceutical product. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, was awarded without set-aside restrictions through competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,198.43 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packages) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.15 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packages) on September 18, 2025, with completion targeted for September 19, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical will be...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB26FSUFLDelivery Order
The Defense Logistics Agency awarded a $13,027.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. This is a non-set-aside competitive award with performance to be completed by November 10, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical supplier to federal medical procurement, particularly for military and veteran healthcare systems. The company's SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. This delivery order for contraceptive tablets reflects the company's role in providing specialized pharmaceutical products across multiple therapeutic domains to support military personnel healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 11/7/25 |